OncoDNA: Bernard Courtieu, Jean-Pol Detiffe, Eduardo Bravo

OncoDNA has appointed Bernard Courtieu as CEO and Jean-Pol Detiffe as chief strategic and innovation officer. Courtieu previously served as CEO of IntegraGen, which was acquired by OncoDNA last July. Prior to IntegraGen, Courtieu served as VP at Gemini Consulting.

Eduardo Bravo, who currently serves as interim CEO of OncoDNA, will remain a consultant to the firm's board.